The business management software producer floated above its range in an offering that allowed Cisco to exit, and which could reach $110m in size.

The Malin-backed dermatology treatment developer floated at the bottom of its range, but is currently 65% up after its first day of trading.

The company database and news app operator, backed by GMO, Yahoo Japan, Itochu and Kodansha, will float in its home country of Japan next month.

The nitric-oxide skin therapeutics developer will use the proceeds to fund late-stage clinical trials for acne, skin infection and fungal infection treatments.

The biotech company is seeking up to $45m from an initial public offering that will be conducted in April or May 2017, and is currently raising more funding.

Johnson & Johnson, Eli Lilly and Pharmstandard exited the IBD treatment developer through an initial public offering that could eventually reach $103m in size.

The item tracking technology producer, which has also received funding from UPS and Unilever in the past, floated at the top of its range.

Alibaba and Legend Holdings have achieved exits as the chauffeured lift service, spun out of CAR 18 months ago, floated in China.

Naver has successfully spun out its Japan-based messaging app subsidiary Line, pricing its shares at the top of their range in a US and Japan flotation.

The genomic medicine company initially raised $50m in an offering that enabled WuXi PharmaTech to exit, before its stock rose significantly post-IPO.